Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Kamal Biswas.
    Summary: The pharmaceutical industry needs a shot in the arm - and not a moment too soon. The executive suite is mired in a bygone era, a time when extensive, well-funded pharmaceutical R & D produced blockbuster drugs, kept everything in-house and reaped the financial rewards. But that way of working needs to change. Executives now need to know what the technologists in their companies are doing in order to survive the next decade. Written for those new to industry, as well as for experienced professionals or specialists looking to expand their knowledge, this book is a must-read for business executive.

    Contents:
    1.Pharma Health
    Critical Parts Need Redesigning
    2.The Pharmaceutical Value Chain
    An Introduction
    Drug Discovery
    Development
    Manufacturing
    Supply Chain Management
    Marketing
    Sales
    Regulatory Compliance
    Finance and Accounts
    Human Resources
    3.Technology Basics
    An Introduction
    Packaged and Custom Developed Technology Solutions
    Computer System Validation
    21 CFR Part 11 Compliance
    4.Courageous New World: Strategies to Improve Business Outcomes
    Staggering Genius in the Crowd: Nextgen R&D
    Feed Your Workhorse: Smarter Manufacturing
    Product Fast-Track: Remodel the Supply Chain
    In Digital We Trust: Industrialize Customer Centricity
    Scream With Mouth Shut: Global Compliance Strategy
    Why Patients Continue With Medicine: Patient Adherence
    The Perks in Emerging Markets: Go Global
    5.Measuring Business Values and Success
    The Pharma Value Cycle: How to Redefine Stakeholder Values
    The Unbearable Financials: Models to Realize Financial Value.
    Digital Access ScienceDirect 2014
  • Article
    Ghimicescu R.
    MMW Munch Med Wochenschr. 1978 Jun 30;120(26):901-4.
    Biarison was tested in 24 patients mainly with classical rheumatoid arthritis for its efficacy and tolerance. There was a distinct improvement in the course of the 4 weeks' therapy with a mean dosage of 900 mg/day (it was in the meantime raised to a maximum of 1500 mg/day in isolated cases) especially in the pain, stiffness and functional capacity. Biarison caused few gastrointestinal side effects: the tolerance may be said to be good on the whole.
    Digital Access Access Options